Moneycontrol PRO

business

Looking to launch 6-7 products over next 2-3 yrs: GSK Pharma

Andrew Aristidou, CFO and ED Finance, GSK Pharma, speaks about the company‘s new launches and why GSK Pharma is in no rush to delist in India.

first published: Jun 8, 2016 10:58 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347